可手术三阴性乳腺癌中18F-FDG PET/CT淋巴结代谢与体积参数对复发的预测
研究纳入228例术前接受18F-FDG PET/CT的可手术三阴性乳腺癌女性患者,评估肿瘤与淋巴结的代谢及体积参数对复发的预测价值。淋巴结各代谢与体积参数在复发与未复发患者间均有显著差异,而肿瘤参数无显著差异;多因素分析中SUVmax-N、MTV与TLG及TNM分期为显著参数。结论认为淋巴结代谢与体积参数是术后复发的显著预测因素。
要点
- 淋巴结代谢与体积参数在复发与未复发患者间均有显著差异。
- 肿瘤代谢与体积参数在复发与未复发患者间无显著差异。
- 多因素分析中SUVmax-N、MTV、TLG及TNM分期为显著参数。
核心结论
- 淋巴结代谢与体积参数是三阴性乳腺癌患者术后复发的显著预测因素。
- 18F-FDG PET/CT的淋巴结代谢与体积参数而非肿瘤参数有助于评估三阴性乳腺癌预后。
研究设计与样本
- 纳入228例可手术三阴性乳腺癌女性患者,平均年龄47.0 ± 10.8岁,均于术前接受18F-FDG PET/CT。
- 分别评估肿瘤(T)与淋巴结(N)的代谢参数(SUVmax、SUVpeak、SUVmean)和体积参数(MTV、TLG),并与临床病理参数比较预后价值。
主要发现
- 淋巴结所有代谢与体积参数在复发与未复发患者间均有显著差异。
- 肿瘤代谢与体积参数在复发与未复发患者间无显著差异。
- 单因素生存分析中,淋巴结所有代谢与体积参数(SUVmax-N、SUVpeak-N、SUVmean-N、MTV-N、TLG-N;均P < 0.001)、T分期(P = 0.010)、N分期(P < 0.001)和TNM分期(P < 0.001)为显著参数。
- 多因素生存分析中,SUVmax-N(P = 0.005)、MTV(P = 0.008)、TLG(P = 0.006)及TNM分期(均P < 0.001)为显著参数。
临床怎么用
- 原文结论认为淋巴结代谢与体积参数可用于评估三阴性乳腺癌患者预后,而非肿瘤参数。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Triple-negative breast cancer has a poor prognosis. We evaluated several metabolic and volumetric parameters from preoperative 18F-fluorodeoxyglucose (FDG) positron emission tomography (PET)/computed tomography (CT) in the prognosis of triple-negative breast cancer and compared them with current clinicopathologic parameters. METHODS: A total of 228 patients with triple-negative breast cancer (mean age 47.0 ± 10.8 years, all women) who had undergone preoperative PET/CT were included. The PET/CT metabolic parameters evaluated included maximum, peak, and mean standardized uptake values (SUVmax, SUVpeak, and SUVmean, respectively). The volumetric parameters evaluated included metabolic tumor volume (MTV) and total lesion glycolysis (TLG). Metabolic and volumetric parameters were evaluated separately for tumor (T) and lymph nodes (N). The prognostic value of these parameters was compared with that of clinicopathologic parameters. RESULTS: All lymph node metabolic and volumetric parameters showed significant differences between patients with and without recurrence. However, tumor metabolic and volumetric parameters showed no significant differences. In a univariate survival analysis, all lymph node metabolic and volumetric parameters (SUVmax-N, SUVpeak-N, SUVmean-N, MTV-N, and TLG-N; all P < 0.001), T stage (P = 0.010), N stage (P < 0.001), and TNM stage (P < 0.001) were significant parameters. In a multivariate survival analysis, SUVmax-N (P = 0.005), MTV (P = 0.008), and TLG (P = 0.006) with TNM stage (all P < 0.001) were significant parameters. CONCLUSIONS: Lymph node metabolic and volumetric parameters were significant predictors of recurrence in patients with triple-negative breast cancer after surgery. Lymph node metabolic and volumetric parameters were useful parameters for evaluating prognosis in patients with triple-negative breast cancer by 18F-FDG PET/CT, rather than tumor parameters.
引用
- Kim YI, Kim YJ, Paeng JC, et al. Prediction of breast cancer recurrence using lymph node metabolic and volumetric parameters from 18F-FDG PET/CT in operable triple-negative breast cancer. Eur J Nucl Med Mol Imaging. 2017. PMID: 28616695. doi:10.1007/s00259-017-3748-7
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。